RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment ...

Foresee Pharmaceuticals (TPEx: 6576) ('Foresee') announced today that it will actively participate in and Toby Maher, M.D., will deliver a keynote presentation titled 'SyMMPonia: A Phase 2 Study of ...

The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...

The device helps identify NSCLC subjects who are likely to benefit from Daiichi Sankyo and AstraZeneca’s Datroway’s treatment ...

Mass General Brigham researchers created an AI tool that uses a simple face photograph to predict how well a patient may fare ...

AI in India addresses radiologist shortage by halving reporting times, increasing accuracy, and aiding in rural healthcare.

Researchers in Nikolaus Rajewsky’s lab at Max Delbrück Center combined high-resolution, single-cell spatial technologies to ...

For Charles Awoniyi, he stands at the forefront of healthcare transformation, leveraging his expertise in artificial ...

The first AI-powered companion diagnostic for non-small cell lung cancer has received FDA Breakthrough Device Designation.

it provides relative functional information related to pulmonary ventilation and circulation. Given the advantages of DCR, it may be a useful tool for identifying disease characteristics where ...

MHE: What are the latest insights into the underlying pathophysiology of pulmonary arterial hypertension (PAH ... Enhanced imaging technology in echocardiography has come to provide clearer images for ...

pulmonary hypertension, and right ventricular hypertrophy. The new study in The American Journal of Pathology details the potential for the model to unravel the complex interactions between lung ...